Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Biosimilars
Sort By
Newest First
1 / 4
Biosimilars
Biosimilars Through the Years: Transforming Access and Cost in Biologics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-01
Mar 02, 2025
Large Molecule
Managing Pharmacovigilance Challenges for Biosimilars
Ivana Lisec, MPharm
PrimeVigilance
PAO-11-24-CL-05
Jan 02, 2025
Tanvex Biopharma
Biosimilars
Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
Tanvex Biopharma
PR-09-24-NI-02
Sep 05, 2024
Biosimilars
Biosimilars: Manufacturing and Supply Chain for Worldwide Patients
Paula Olcese
Biosidus
PAO-08-24-CL-06
Aug 07, 2024
Biosimilars
Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-06
Jul 16, 2024
Biosimilars
Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-07
Jul 16, 2024
Biosimilars
Navigating the Global Regulatory Landscape for Biosimilars
Veronica Grimoldi
Biosidus
PAO-07-24-CL-09
Jul 16, 2024
Chronic Diseases
Transforming the Management of Chronic Diseases with Biosimilars
Hugo Sotelo; Jorge Catella
Biosidus
PAO-07-24-CL-10
Jul 16, 2024
Analytical Method Development
Harnessing Biologic Development Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development
Xuemei Han, Ph.D.
Tanvex CDMO
PAO-03-24-CL-09
Mar 13, 2024
Biotherapeutics
Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO
John R. Mosack
Tanvex CDMO
PAO-10-23-CL-05
Nov 07, 2023
Interchangeable Biosimilars
The Opportunities and Challenges Posed by Biosimilar Interchangeability
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-01
Mar 07, 2023
Life Science Industrials
Filling Industry Gaps and Driving Innovation with Life Science Industrials
Reinhard Vogt; Sebastien Latapie
Dynamk Capital
PAO-11-21-CL-01
Nov 03, 2021
Biogen
Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra®
Biogen
PR-M06-21-010
Jun 08, 2021
Clinical Trial Logistics
Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies
Mark Woolf
Catalent
PAO-03-21-CL-06
Mar 22, 2021
Biosimilars
Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience
Richard Richieri
Avid Bioservices
PAO-03-21-CL-03
Mar 18, 2021
Parenterals
Trends Shaping the Dynamic Market for Parenterals
Marga Viñes
Grifols
PAP-Q3-20-CL-018
Sep 29, 2020
The Future of Healthcare
How Is Polpharma Biologics Evolving its Business Model to Meet the Future of Healthcare?
Polpharma Biologics
PAP-Q3-20-RT2-007
Sep 29, 2020
The Future of Healthcare
How is Polpharma Biologics Innovating through the Integration of Advanced Cell Line Development Capabilities to Help Shape the Future of Healthcare?
Polpharma Biologics
PAP-Q2-20-RT2-004
Jul 01, 2020
U.S. Food & Drug Administration
Biosimilars
FDA Statement on Low-Cost Biosimilar and Interchangeable Protein Products
U.S. Food & Drug Administration
PR-M12-19-NI-037
Dec 20, 2019
Biosimilars
Numerous Biosimilar Launches Coming Soon in United States
Pharma's Almanac
PAO-M12-19-NI-007
Dec 13, 2019
1 / 4
